Shanghai Kinetic Medical Co., Ltd (SHE:300326)
China · Delayed Price · Currency is CNY 6.48
+0.03 (0.47%)
Nov 13, 2026, 3:04 PM CST
Shanghai Kinetic Medical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 4,646 | 4,073 | 4,661 | 4,539 | 5,163 | 7,586 | |
Market Cap Growth | 12.31% | -12.62% | 2.69% | -12.08% | -31.95% | -33.01% |
Enterprise Value | 3,042 | 3,170 | 3,946 | 3,853 | 4,549 | 7,276 |
Last Close Price | 6.48 | 5.59 | 6.39 | 6.13 | 6.97 | 10.26 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 17.29 | 30.19 | - | 40.33 | - | 46.89 |
Forward PE | - | 32.97 | 32.97 | 25.89 | 15.73 | 26.00 |
PS Ratio | 6.33 | 4.23 | 4.73 | 4.75 | 4.43 | 5.98 |
PB Ratio | 1.57 | 1.41 | 1.65 | 1.54 | 1.83 | 2.73 |
P/TBV Ratio | 1.97 | 1.75 | 2.26 | 2.06 | 2.47 | 3.95 |
P/FCF Ratio | 22.26 | 33.14 | 62.22 | 20.59 | 26.43 | 23.06 |
P/OCF Ratio | 20.16 | 21.54 | 29.54 | 16.55 | 21.81 | 20.06 |
PEG Ratio | - | 0.98 | 0.98 | 0.98 | 0.98 | 0.98 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 4.14 | 3.29 | 4.01 | 4.03 | 3.90 | 5.74 |
EV/EBITDA Ratio | 19.01 | 29.00 | 26.55 | 26.46 | 16.65 | 21.58 |
EV/EBIT Ratio | 28.14 | 52.90 | 49.88 | 48.30 | 21.43 | 25.95 |
EV/FCF Ratio | 14.58 | 25.80 | 52.68 | 17.48 | 23.29 | 22.12 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.02 | 0.02 | 0.12 | 0.07 | 0.12 | 0.15 |
Debt / EBITDA Ratio | 0.31 | 0.43 | 2.20 | 1.35 | 1.20 | 1.26 |
Debt / FCF Ratio | 0.24 | 0.44 | 4.36 | 0.89 | 1.68 | 1.29 |
Net Debt / Equity Ratio | -0.55 | -0.50 | -0.32 | -0.29 | -0.23 | -0.17 |
Net Debt / EBITDA Ratio | -11.47 | -13.38 | -6.00 | -5.80 | -2.35 | -1.43 |
Net Debt / FCF Ratio | -7.82 | -11.90 | -11.91 | -3.83 | -3.29 | -1.46 |
Asset Turnover | 0.22 | 0.30 | 0.29 | 0.28 | 0.34 | 0.35 |
Inventory Turnover | 0.87 | 1.41 | 1.35 | 1.30 | 1.33 | 1.84 |
Quick Ratio | 12.18 | 10.41 | 3.32 | 3.98 | 2.59 | 2.58 |
Current Ratio | 14.41 | 12.47 | 4.25 | 5.19 | 3.35 | 3.16 |
Return on Equity (ROE) | 8.81% | 4.61% | -3.34% | 4.39% | -0.86% | 6.40% |
Return on Assets (ROA) | 2.07% | 1.17% | 1.47% | 1.47% | 3.83% | 4.87% |
Return on Invested Capital (ROIC) | 7.55% | 3.23% | 3.93% | 3.54% | 9.50% | 10.21% |
Return on Capital Employed (ROCE) | 3.60% | 2.10% | 2.70% | 2.60% | 7.40% | 9.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 5.78% | 3.31% | -2.27% | 2.48% | -0.41% | 2.13% |
FCF Yield | 4.49% | 3.02% | 1.61% | 4.86% | 3.78% | 4.34% |
Dividend Yield | 1.54% | 1.76% | - | 0.95% | - | 0.47% |
Payout Ratio | 27.06% | 3.41% | - | 4.54% | - | 33.91% |
Buyback Yield / Dilution | -0.04% | 0.01% | -0.05% | 0.31% | 0.40% | 0.16% |
Total Shareholder Return | 1.51% | 1.77% | -0.05% | 1.26% | 0.40% | 0.64% |